{"podcast":{"title":"EP Edge Journal Watch","slug":"ep-edge-journal-watch-7561379","podcast_index_feed_id":7561379,"rss_url":"https://feeds.transistor.fm/ep-edge-journal-watch","website_url":null,"image_url":"https://img.transistorcdn.com/KWuXQ6fPAArQRCgfrqrxfzQNWh_DnAU4t75wkubUSk4/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jMzFi/ZTYxOTI1M2U4NGRj/OGZmZjBhMDFlMjFm/NDQwMC5wbmc.jpg","author":"Niraj Sharma","episode_count":37,"summary":"Welcome to EP Edge Journal Watch — where cardiac electrophysiology meets evidence, precision, and perspective. Hosted by Dr. Niraj Sharma, this bi-weekly podcast distills high-impact cardiovascular and EP research into clear, clinically meaningful insights. Each episode goes beyond headlines and abstracts to uncover what new studies actually mean for patient care, decision-making, and the future of electrophysiology. What EP Edge Journal Watch stands for: Evidence-based practice Precision electrophysiology A forward-thinking, edge-driven approach to how we interpret and apply data in real-world clinical settings. Whether you’re an electrophysiologist, cardiologist, researcher, trainee, or allied health professional, EP Edge Journal Watch brings you the signal — not the noise. Expect sharp summaries, thoughtful commentary, and practical takeaways designed for the busy clinician who wants to stay ahead of the curve","last_synced_at":"2026-07-20T20:18:25.367003+00:00","page_url":"https://stenobird.com/podcast/ep-edge-journal-watch-7561379"},"episode":{"title":"EP Edge Journal Watch Special Edition: VOLT IDE One-Year Results in Context: ADVENT, ADVANTAGE-AF, AdmIRE, SPHERE-Per-AF & U.S. PFA Pivotal Trials","slug":"ep-edge-journal-watch-special-edition-volt-ide-one-year-results-in-context-advent-advantage-af-admire-sphere-per-af-u-s-pfa-pivotal-trials","published_at":"2026-02-06T19:19:46+00:00","page_url":"https://stenobird.com/podcast/ep-edge-journal-watch-7561379/ep-edge-journal-watch-special-edition-volt-ide-one-year-results-in-context-advent-advantage-af-admire-sphere-per-af-u-s-pfa-pivotal-trials","show_page_url":"https://stenobird.com/podcast/ep-edge-journal-watch-7561379","url":"https://share.transistor.fm/s/fd4a1bb4","audio_url":"https://media.transistor.fm/fd4a1bb4/0c45f488.mp3","summary":"Pulsed field ablation (PFA) has rapidly reshaped atrial fibrillation ablation, but true clinical validation depends on durable one-year outcomes, not early feasibility or acute safety alone . In this EP Edge Journal Watch Special Edition , Dr. Niraj Sharma delivers a comprehensive, system-level analysis of the Abbott VOLT IDE one-year data , now completing the 12-month efficacy and safety landscape across major U.S. PFA platforms. This episode critically reviews and contextualizes results from the VOLT IDE trial alongside other pivotal and near-pivotal studies, including ADVENT , ADVANTAGE-AF , AdmIRE , SPHERE-9 first-in-human , and SPHERE-Per-AF . The discussion spans paroxysmal, persistent, and advanced AF populations , with attention to how ablation strategy (PVI-only vs adjunctive lesions), patient risk profile, and post-ablation monitoring intensity influence reported outcomes. Key themes include one-year efficacy versus composite effectiveness , freedom from atrial arrhythmias, repeat procedures, and major safety endpoints such as stroke, tamponade, and esophageal injury. Rather than ranking technologies, this episode emphasizes methodology, trial design, and clinical context , explaining why efficacy signals differ across studies and how these data should be interpreted in everyday electrophysiology practice. For additional references, detailed tables, graphics, and deeper comparative analysis , visit the LinkedIn EP Edge newsletter and Substack at ephedge.substack.com . If you have suggestions or concerns, you can reach Dr. Sharma at ephedgecast@gmail.com","meta_description":"Pulsed field ablation (PFA) has rapidly reshaped atrial fibrillation ablation, but true clinical validation depends on durable one-year outcomes, not earl…","key_points":[],"chapters":[],"topics":[],"duration_seconds":566,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/ep-edge-journal-watch-7561379/episodes/ep-edge-journal-watch-special-edition-volt-ide-one-year-results-in-context-advent-advantage-af-admire-sphere-per-af-u-s-pfa-pivotal-trials/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/ep-edge-journal-watch-7561379/ep-edge-journal-watch-special-edition-volt-ide-one-year-results-in-context-advent-advantage-af-admire-sphere-per-af-u-s-pfa-pivotal-trials.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}